Delivery of avian cytokines by adenovirus vectors

Developmental and Comparative Immunology

Volumn 24, Issue 2-3, 2000, Pages 343-354

  Johnson, Michael A ^a   Pooley, Cathryn ^a   Lowenthal, John W ^a  

^a CSIRO   (Australia)

Author keywords

Chicken growth; Coccidiosis; Cytokines; Fowl adenovirus; Interferon

Indexed keywords

GAMMA INTERFERON; SPLICED LEADER RNA; VIRUS VECTOR;

ANIMAL DISEASE; AVIADENOVIRUS; CHICKEN; EIMERIA; GENE CONSTRUCT; GENE DELETION; GENE INSERTION; GENE TARGETING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROTYPE; VIRUS RECOMBINANT; WEIGHT GAIN;

ACERVULINA; ADENOVIRIDAE; ANIMALIA; AVES; AVIADENOVIRUS; EIMERIA; EIMERIA ACERVULINA; FOWL ADENOVIRUS 1; GALLIFORMES; GALLUS GALLUS; RNA VIRUSES;

EID: 0034161747     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-305X(99)00082-8     Document Type: Article

References (45)

1. Ricks C.A., Avakian A., Bryan T., Gildersleeve R., Haddad E., Ilich R., King S., Murray L., Phelps P., Poston R., Whitfill C., Williams C. In ovo vaccination technology. Adv. Vet. Med. 41:1999;495-515.
2. Schijns V.E.C.J., Horzinek M.C. Cytokines in veterinary medicine. 1997;CAB International, Wallingford, UK.
3. Babiuk L.A., Bielefeldt Ohmann H., Gifford G., Czarniecki C.W., Scialli V.T., Hamilton E.G. Effect of bovine alpha interferon on herpesvirus type 1 induced respiratory disease. J. Gen. Virol. 66:1985;2383-2394.
4. Babiuk L.A., Lawman M.J.P., Gifford G.A. Use of recombiant bovine alpha interferon in reducing respiratory disease induced by bovine herpesvirus type 1. Antimicrobial Agents and Chemotheraphy. 31:1987;752-757.
5. Daley M.J., Coyle P.A., Williams T.J., Furda G., Dougherty R., Hayes P.W. Staphylococcus aureus mastitis: pathogenesis and treatment with bovine interleukin-1β and interleukin-2. J. Dairy Sci. 74:1991;4413-4424.
6. Daley M.J., Williams T., Coyle P., Furda G., Dougherty R., Hayes P. Prevention and treatment of Staphylococcus aureus infections with recombinant cytokines. Cytokine. 5:1993;276-284.
7. Sordillo L.M., Babiuk L.A. Controlling acute Escherichia coli mastitis during the periparturient period with recombinant bovine interferon γ Vet. Microbiol. 28:1991;189-198.
8. Sordillo L.M., Peel J.E. Effect of interferon-γ on the production of tumour necrosis factor during acute Escherichia coli mastitis. J. Dairy Sci. 75:1992;2119-2125.
9. Brown-Borg H.M., Klemcke H.G., Blecha F. Lymphocyte proliferative responses in neonatal pigs with high or low cortisol concentration after stress induced by restraint. Am. J. Vet. Res. 4:1993;2015-2020.
10. Bailey M., Clarke C.J., Wilson A.D., Williams N.A., Stokes C.R. Depressed potential for interleukin-2 production following early weaning in piglets. Vet. Immun. Immunopath. 34:1992;197-207.
11. Nowacki W., Cederbald B., Renard C., La Bonnardière C., Charley B. Age-related increase of porcine natural interferon α producing cell frequency and interferon yield per cell. Vet. Immun. Immunopath. 37:1993;113-122.
12. Becker B.A., Misfeldt M.L. Evaluation of mitogen-induced proliferation and cell surface differentiation antigens of lymphocytes from pigs 1 to 30 days of age. J. Animal Sci. 71:1993;2073-2078.
13. Baca-Estrada M.E., Godson D.L., Hughes H.P.A., Van Donkersgoed J., Van Kessel A., Harland R., Shuster D.E., Daley M., Babiuk L.A. Effect of recombinant bovine interleukin 1 β on viral bacterial pneumonia in cattle. J. Interferon Cytokine Res. 15:1995;431-439.
14. Van Kessel A.G., Godson D.L., Baca-Estrada M.E., Morsy M.A., Hughes H.P.A., Harland R.J., Shuster D.E., Daley M.J., Babiuk L.A. Effect of recombinant bovine interleukin-1β in normal calves and calves infected with bovine herpesvirus type 1. J. Interferon Cytokine Res. 16:1996;881-890.
15. Reddy D.N., Reddy P.G., Minocha H.C., Fenwick B.W., Baker P.E., Davis W.C., Blecha F. Adjuvanticity of recombinant bovine Interleukin-1β: influence on immunity, infection and latency in a bovine herpesvirus-1 infection. Lymphokine Res. 9:1990;295-307.
16. Reddy D.N., Reddy P.G., Xue W., Minocha H.C., Daley M.J., Blecha F. Immunopotentiation of bovine respiratory disease virus vaccine by interleukin-1β and interleukin-2. Vet. Immun. Immunopath. 37:1993;25-38.
17. Hughes H.P.A., Campos M., Godson D.L., Van Drunen Den Little.-Van Hurk S., McDougall L., Rapin N., Zamb T., Babiuk L.A. Immunopotentiation of bovine herpes virus subunit vaccination by interleukin-2. Immunology. 74:1991;461-466.
18. Hughes H.P.A., Campos M., Van Drunen Den Little.-Van Hurk S., Zamb T., Sordillo M., Godson D.L., Babiuk L.A. Multiple administration with interleukin-2 potentiates antigen-specific responses to subunit vaccination with bovine herpesvirus-1 glycoprotein IV. Vaccine. 10:1992;226-230.
19. Andrews A.E., Lofthouse S.A., Bowles V.M., Brandon M.R., Nash A.D. Production and in vivo use of recombinant ovine interleukin-1β as an immunological adjuvant. Vaccine. 12:1994;14-24.
20. Nash A.D., Lofthouse S.A., Barcham G.J., Jacobs H.J., Ashman K., Meeusen E.N.T., Brandon M.R., Andrews A.E. Recombinant cytokines as immunological adjuvants. Immun. Cell Biol. 71:1993;367-379.
21. Lofthouse S.A., Andrews A.E., Nash A.D., Bowles V.M. Humoral and cellular-responses induced by intradermally administered cytokine and conventional adjuvants. Vaccine. 13:1995;1131-1137.
22. Heath A.W., Devey M.E., Brown I.N., Richards C.E., Playfair J.H.L. Interferon-gamma as an adjuvant in immunocompromised mice. Immunology. 67:1989;520-524.
23. Anderson K.P., Fennie E.H., Yilmo T. Enhancement of a secondary antibody response to vesicular stomatitis virus G protein by IFN-γ treatment at primary immunisation. J. Immun. 140:1989;3599-3604.
24. Cao M., Saski O., Yamada A., Imanishi J. Enhancement of the protective effect of inactivated influenza virus vaccine by cytokines. Vaccine. 10:1992;238-242.
25. Stoekle M.Y., Falck-Peterson E., Rubin B.Y., Anderson S.L., Murray H.W. Delivery of human interferon-γ via gene transfer in vitro: prolonged expression and induction of macrophage antimicrobial activity. J. Interferon Cytokine Res. 16:1996;1015-1019.
26. Sheppard M., Werner W., Tstas E., McCoy R., Prowse S., Johnson M. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Arch. Virol. 143:1998;915-930.
27. Pallister J.A., Erny K.M., Fahey K.J. Serological relationships within the Group E fowl adenoviruses. Intervirol. 36:1993;84-90.
28. Pallister J.A., Sheppard M. Comparison by restriction enzyme analysis of three fowl adenoviruses of varying pathogenicity. Vet. Micro. 48:1996;155-163.
29. Sheppard M., Werner W., McCoy R.J., Johnson M.A. The major late promoter and bipartite leader sequence of fowl adenovirus. Arch. Virol. 143:1998;537-548.
30. Digby M.R., Lowenthal J.W. Cloning and expression of the chicken interferon-γ gene. J. Interferon Cytokine Res. 15:1995;939-945.
31. Chiocca S., Kurzbauer R., Schaffner G., Baker A., Mautner V., Cotton M. The complete DNA sequence and genomic organization of the avian adenovirus CELO. J. Virol. 70:1996;2939-2949.
32. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl. Acids Res. 25:1997;3389-3402.
33. Lowenthal J.W., Digby M.R., York J.J. Production of interferon-γ by chicken cells. J. Interferon Cytokine Res. 15:1995;933-938.
34. Lowenthal J.W., York J.J., O'Neil T.E., Rhodes S., Prowse S.J., Strom A.D.G., Digby M.R. In vivo effects of chicken interferon gamma during infection with Eimeria. J. Interferon Cytokine Res. 17:1997;551-558.
35. Lillehoj H.S., Choi K.D. Recombinant chicken interferon-gamma mediated inhibition of Eimeria tenella development in vitro and reduction of oocyst production and body weight loss following Eimeria acervulina challenge infection. Avian Dis. 42:1998;307-314.
36. Rosenthal K.L., Copeland K.F.T., Gallichan W.S. Recombinant Adenoviruses as vectors for mucosal immunity. Kiyono H., Ogra P.L., McGhee J.R. Mucosal Vaccines. 1996;147-158 Academic Press, San Diego.
37. Pallister J., Wright P.J., Sheppard M. A single gene encoding the fiber is responsible for variations in virulence in the fowl adenoviruses. J. Virol. 70:1996;5115-5122.
38. Yang Y., Wilson J.M. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immun. 155:1995;2564-2570.
39. Yang Y., Trinchieri G., Wilson J.M. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med. 1:1995;890-893.
40. Schulick A.H., Vassalli G., Dunn P.F., Dong G., Rade J.J., Zamarron C. Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity. J. Clin. Invest. 99:1997;209-219.
41. Dong J.Y., Wang D., van Ginkel F.W., Pascual D.W., Frizzell R.A. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector. Hum. Gene Ther. 7:1996;319-331.
42. Zabner J., Petersen D.M., Puga A.P., Graham S.M., Couture L.A., Keyes L.D., Lukason M.J., St George J.A., Gregory R.J., Smith A.E., Welsh M.J. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat. Genet. 6:1994;75-83.
43. Papp Z., Babiuk L.A., Baca-Estrada M.E. The effect of pre-existing adenovirus specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1. Vaccine. 17:1999;933-943.
44. Erny K. Immunobiology and molecular virology of fowl adenoviruses. PhD thesis, The University of Melbourne, 1990.
45. York J.J., Strom A.D.G., Connick T.E., McWaters P.G., Boyle D.B., Lowenthal J.W. In vivo effects of chicken myelomonocytic growth factor: delivery via a viral vector. J. Immun. 156:1996;2991-2997.